Lazard Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12,222
| Closed | -$376K | – | 2098 |
|
|
2023
Q4 | $376K | Buy |
+12,222
| New | +$376K | ﹤0.01% | 1192 |
|
|
2023
Q1 | – | Sell |
-2,851
| Closed | -$66K | – | 2335 |
|
|
2022
Q4 | $66K | Sell |
2,851
-37,312
| -93% | -$864K | ﹤0.01% | 1680 |
|
|
2022
Q3 | $643K | Buy |
40,163
+8,858
| +28% | +$142K | ﹤0.01% | 1056 |
|
|
2022
Q2 | $554K | Buy |
31,305
+14,797
| +90% | +$262K | ﹤0.01% | 1093 |
|
|
2022
Q1 | $336K | Sell |
16,508
-4,427
| -21% | -$90.1K | ﹤0.01% | 1169 |
|
|
2021
Q4 | $391K | Buy |
+20,935
| New | +$391K | ﹤0.01% | 1148 |
|
|
2021
Q3 | – | Sell |
-2,811
| Closed | -$66K | – | 2171 |
|
|
2021
Q2 | $66K | Sell |
2,811
-7,664
| -73% | -$180K | ﹤0.01% | 1487 |
|
|
2021
Q1 | $248K | Sell |
10,475
-25,646
| -71% | -$607K | ﹤0.01% | 1071 |
|
|
2020
Q4 | $723K | Buy |
36,121
+3,946
| +12% | +$79K | ﹤0.01% | 934 |
|
|
2020
Q3 | $669K | Sell |
32,175
-15,236
| -32% | -$317K | ﹤0.01% | 845 |
|
|
2020
Q2 | $829K | Buy |
+47,411
| New | +$829K | ﹤0.01% | 777 |
|
|
2018
Q3 | – | Sell |
-8,405
| Closed | -$200K | – | 1057 |
|
|
2018
Q2 | $200K | Hold |
8,405
| – | – | ﹤0.01% | 847 |
|
|
2018
Q1 | $214K | Buy |
+8,405
| New | +$214K | ﹤0.01% | 836 |
|